UNICEF Supply Division is responsible for procuring vaccines and devices for countries on behalf of GAVI Alliance, a broad partnership of public and private organizations managed by the GAVI Secretariat - Swiss Foundation, and directed by a Board of stakeholders. The GAVI Board approves country programmes based on a set of specific criteria: From 2011 each country must have a gross national product per capita less than $1,500 (as per World Bank data); a current routine coverage of diphtheria/tetanus/pertussis (DTP3) vaccine greater than 70 per cent; a functioning Inter-Agency Co-ordinating Committee; a comprehensive multi-year immunization plan.
In 2010, procurement on behalf of GAVI was about $360 million, delivered to 64 countries, primarily for new and under-used vaccines, specifically against Hepatitis B, Hib, and yellow fever and meningococcal in endemic countries. 2 GAVI supported countries also introduced pneumococcal vaccine.
Supply agreements were established for the period 2010-2012 for all the GAVI supported vaccines. Sufficient supply was offered to meet forecasted demand for all vaccines. Significant price reductions were achieved for the pentavalent vaccines (DTP-HepB/Hib). Please click here for price projections/product menu.
Following the launch in June 2009, the first supply arrangements under the pneumococcal Advance Market Commitment were entered into in March 2010. This innovative financing mechanism will allow access to pneumococcal vaccines for children in GAVI supported countries at the same time as the vaccines are being introduced in developed countries. Please click here for details.
More about GAVI (this link opens in a new window and will take you to a non-UNICEF website):